Literature DB >> 1847999

Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.

S Hosono1, C S Lee, M J Chou, C S Yang, C H Shih.   

Abstract

We have examined p53 oncogene/anti-oncogene alleles in 10 different human hepatoma cell lines and 18 primary hepatocellular carcinomas. The p53 allele in these hepatoma cell lines appears to be a frequent target of mutation as demonstrated by Southern and Northern blotting, immunoprecipitation and Western blot analysis. In general, the steady state level of p53 specific RNA or protein in these hepatoma cell lines is higher than in normal liver. However, in three out of ten cell lines, normal-sized p53 mRNA cannot be detected. In contrast, the involvement of the p53 allele in primary hepatocellular carcinoma appears to be an exceedingly rare event. Steady state levels of p53 specific RNA in primary hepatomas are practically indistinguishable from those in normal adult liver. Using the polymerase chain reaction technique, we have amplified and subcloned exons 5, 6, 7 and 8 of p53 from 10 different hepatoma samples. DNA sequence analysis of these exon subclones reveals no apparent structural alterations. Finally, synthesis of p53 specific mRNA or protein in a HepG2 human hepatoblastoma cell line does not appear to be affected by gene expression and replication of human hepatitus B virus. Surprisingly, unlike many other kinds of human solid tumors, point mutations in p53 do not appear to be important in primary tumors of hepatocellular carcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847999

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells.

Authors:  Lauren E Nelson; Rudy J Valentine; José M Cacicedo; Marie-Soleil Gauthier; Yasuo Ido; Neil B Ruderman
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

2.  β-catenin accumulation in nuclei of hepatocellular carcinoma cells up-regulates glutathione-s-transferase M3 mRNA.

Authors:  Yu-Sang Li; Min Liu; Yoshihiro Nakata; He-Bin Tang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.

Authors:  Kevin M Beggs; Ashley R Maiuri; Aaron M Fullerton; Kyle L Poulsen; Anna B Breier; Patricia E Ganey; Robert A Roth
Journal:  Toxicology       Date:  2015-03-05       Impact factor: 4.221

4.  Expression of mutant p53 protein in hepatocellular carcinoma.

Authors:  J D Collier; M Carpenter; A D Burt; M F Bassendine
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 5.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.

Authors:  Martha L Peterson; Chunhong Ma; Brett T Spear
Journal:  Semin Cancer Biol       Date:  2011-01-07       Impact factor: 15.707

6.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.

Authors:  A Moustakas; D Kardassis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis.

Authors:  L Tessitore; I Dianzani; Z Cui; D E Vance
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

9.  Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas.

Authors:  K H Buetow; V C Sheffield; M Zhu; T Zhou; F M Shen; O Hino; M Smith; B J McMahon; A P Lanier; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 10.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.